I. Stromberg et al., Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons, MICROSC RES, 54(5), 2001, pp. 287-297
Clinical and experimental grafting in Parkinson's disease has shown the nee
d for enhanced survival of dopamine neurons to obtain improved functional r
ecovery. In addition, it has been suggested that a limited number of surviv
ing dopamine neurons project to the dopamine-denervated host striatum. The
aim of this study was to investigate if subpopulations of ventral mesenceph
alic dopamine neurons project to their normal targets, i.e., dorsal vs. ven
tral striatum. Following implantation of human ventral mesencepahlic tissue
into the lateral ventricle of dopamine-depleted rats, human-derived dopami
ne reinnervation was achieved both in dorsal and ventral striatum. Treatmen
t with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) r
esulted in a degeneration of tyrosine hydroxylase (TH)-immunoreactive nerve
fibers in dorsal striatum but not in ventral areas in some animals, while
MPTP was without effect in other animals. TH-immunoreactive neurons were sm
all and appeared shrunken in animals carrying grafts affected by the MPTP t
reatment. In conclusion, grafted dopamine neurons projected nerve fibers in
to areas that they normally innervate. Thus, when searching for factors tha
t may enhance survival of grafted dopamine neurons it is important to study
which subpopulation(s) of ventral mesencephalic dopamine neurons is affect
ed, such that a proper reinnervation may be achieved. Microsc. Res. Tech. 5
4:287-297, 2001. (C) 2001 Wiley-Liss, Inc.